These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
299 related items for PubMed ID: 8648928
21. Pathogenesis of IgA nephropathy. Feehally J, Allen AC. Ann Med Interne (Paris); 1999 Feb; 150(2):91-8. PubMed ID: 10392257 [Abstract] [Full Text] [Related]
22. Serum IgA and the production of IgA by peripheral blood and bone marrow lymphocytes in patients with primary IgA nephropathy: evidence for the bone marrow as the source of mesangial IgA. van den Wall Bake AW, Daha MR, Evers-Schouten J, van Es LA. Am J Kidney Dis; 1988 Nov; 12(5):410-4. PubMed ID: 3189325 [Abstract] [Full Text] [Related]
23. Differential glycosylation of polymeric and monomeric IgA: a possible role in glomerular inflammation in IgA nephropathy. Oortwijn BD, Roos A, Royle L, van Gijlswijk-Janssen DJ, Faber-Krol MC, Eijgenraam JW, Dwek RA, Daha MR, Rudd PM, van Kooten C. J Am Soc Nephrol; 2006 Dec; 17(12):3529-39. PubMed ID: 17050773 [Abstract] [Full Text] [Related]
24. Pathogenesis of IgA nephropathy. Barratt J, Feehally J, Smith AC. Semin Nephrol; 2004 May; 24(3):197-217. PubMed ID: 15156526 [Abstract] [Full Text] [Related]
25. Light-chain composition of serum IgA1 and in vitro IgA1 production in IgA nephropathy. Chen N, Nusbaum P, Halbwachs-Mecarelli L, Lesavre P. Nephrol Dial Transplant; 1991 May; 6(11):846-50. PubMed ID: 1775249 [Abstract] [Full Text] [Related]
26. IgA production and tonsillar focal infection in IgA nephropathy. Meng H, Ohtake H, Ishida A, Ohta N, Kakehata S, Yamakawa M. J Clin Exp Hematop; 2012 May; 52(3):161-70. PubMed ID: 23269075 [Abstract] [Full Text] [Related]
27. Analysis of charge distribution of lambda- and kappa-IgA in IgA nephropathy by focused antigen capture immunoassay. Suen KK, Lewis WH, Lai KN. Scand J Urol Nephrol; 1997 Jun; 31(3):289-93. PubMed ID: 9249895 [Abstract] [Full Text] [Related]
28. Pathogenic role of glycan-specific IgG antibodies in IgA nephropathy. Zhao YF, Zhu L, Liu LJ, Shi SF, Lv JC, Zhang H. BMC Nephrol; 2017 Sep 29; 18(1):301. PubMed ID: 28969604 [Abstract] [Full Text] [Related]
29. Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases. Tissandié E, Morelle W, Berthelot L, Vrtovsnik F, Daugas E, Walker F, Lebrec D, Trawalé JM, Francoz C, Durand F, Moura IC, Paradis V, Moreau R, Monteiro RC. Kidney Int; 2011 Dec 29; 80(12):1352-63. PubMed ID: 21866091 [Abstract] [Full Text] [Related]
30. Aberrant glycosylation of IgA1 and anti-glycan antibodies in IgA nephropathy: role of mucosal immune system. Novak J, Moldoveanu Z, Julian BA, Raska M, Wyatt RJ, Suzuki Y, Tomino Y, Gharavi AG, Mestecky J, Suzuki H. Adv Otorhinolaryngol; 2011 Dec 29; 72():60-3. PubMed ID: 21865691 [Abstract] [Full Text] [Related]
31. O-glycoforms of polymeric immunoglobulin A1 in the plasma of patients with IgA nephropathy are associated with pathological phenotypes. Yu G, Zhang Y, Meng B, Xie X, Wang Z, Ying W, Lv J, Zhang H. Nephrol Dial Transplant; 2021 Dec 31; 37(1):33-41. PubMed ID: 34152412 [Abstract] [Full Text] [Related]
32. Activation of tubular epithelial cells by mesangial-derived TNF-alpha: glomerulotubular communication in IgA nephropathy. Chan LY, Leung JC, Tsang AW, Tang SC, Lai KN. Kidney Int; 2005 Feb 31; 67(2):602-12. PubMed ID: 15673307 [Abstract] [Full Text] [Related]
33. IgA1 Protease Treatment Reverses Mesangial Deposits and Hematuria in a Model of IgA Nephropathy. Lechner SM, Abbad L, Boedec E, Papista C, Le Stang MB, Moal C, Maillard J, Jamin A, Bex-Coudrat J, Wang Y, Li A, Martini PG, Monteiro RC, Berthelot L. J Am Soc Nephrol; 2016 Sep 31; 27(9):2622-9. PubMed ID: 26850635 [Abstract] [Full Text] [Related]
34. Compositional similarity between immunoglobulins binding to asialo-, agalacto-IgA1-Sepharose and those deposited in glomeruli in IgA nephropathy. Takatani T, Iwase H, Itoh A, Nakamura I, Hayashi M, Sakamoto H, Kamata K, Kobayashi Y, Hiki Y, Okamoto M, Higashihara M. J Nephrol; 2004 Sep 31; 17(5):679-86. PubMed ID: 15593035 [Abstract] [Full Text] [Related]
35. CCL20 secreted from IgA1-stimulated human mesangial cells recruits inflammatory Th17 cells in IgA nephropathy. Lu G, Zhang X, Shen L, Qiao Q, Li Y, Sun J, Zhang J. PLoS One; 2017 Sep 31; 12(5):e0178352. PubMed ID: 28552941 [Abstract] [Full Text] [Related]
36. Size-dependent binding of IgA to HepG2, U937, and human mesangial cells. Leung JC, Tsang AW, Chan LY, Tang SC, Lam MF, Lai KN. J Lab Clin Med; 2002 Dec 31; 140(6):398-406. PubMed ID: 12486407 [Abstract] [Full Text] [Related]
37. IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells. Novak J, Tomana M, Matousovic K, Brown R, Hall S, Novak L, Julian BA, Wyatt RJ, Mestecky J. Kidney Int; 2005 Feb 31; 67(2):504-13. PubMed ID: 15673298 [Abstract] [Full Text] [Related]
38. Integrin α1/β1 and α2/β1 as a receptor for IgA1 in human glomerular mesangial cells in IgA nephropathy. Kaneko Y, Otsuka T, Tsuchida Y, Gejyo F, Narita I. Int Immunol; 2012 Apr 31; 24(4):219-32. PubMed ID: 22298882 [Abstract] [Full Text] [Related]
39. Sialylation of IgG inhibits the formation of galactose-deficient IgA1-containing immune complexes and protects mesangial cells from injury in IgA nephropathy. Liu Y, Li H, Yu H, Wang F, Jia J, Yan T. BMC Nephrol; 2022 Jan 11; 23(1):25. PubMed ID: 35016642 [Abstract] [Full Text] [Related]
40. Differential effects of circulating IgA isolated from patients with IgA nephropathy on superoxide and fibronectin production of mesangial cells. Chen HC, Guh JY, Chang JM, Lai YH. Nephron; 2001 Jul 11; 88(3):211-7. PubMed ID: 11423751 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]